Lack of bcl-2 Persistence: An Independent Prognostic Indicator of Poor Prognosis in Endometrial Carcinoma
Authors:
- Hans E. GeislerHGHans E. Geisler
- Michael C. WiemannMWMichael C. Wiemann
- Zhen ZhouZZZhen Zhou
- Greg A. MillerGMGreg A. Miller
- William CrabtreeWCWilliam Crabtree
- 1 November 1998
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 71 (2) , 305-307
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- bcl-2 and apoptosis in lymph node positive breast carcinomaCancer, 1998
- Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activityBritish Journal of Cancer, 1998
- Markov Texture Parameters as Prognostic Indicators in Endometrial CancerGynecologic Oncology, 1996
- Proliferation Index Determined by MIB-1 and Recurrence in Endometrial CancerGynecologic Oncology, 1996
- p53 Overexpression and bcl-2 Persistence in Endometrial Carcinoma: Comparison of Papillary Serous and Endometrioid SubtypesGynecologic Oncology, 1996
- bcl-2 Expression, p53 Accumulation, and Apoptosis in Ovarian CarcinomasAmerican Journal of Clinical Pathology, 1996
- Apoptosis and the cell cycle1996
- The possible role of bcl–2 expression in the progression of tumors of the uterine cervixCancer, 1995
- Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cellsNature, 1988
- Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocationCell, 1986